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The recent description of the respiratory pathogen human metapneumovirus (hMPV) has highlighted a
deficiency in current diagnostic techniques for viral agents associated with acute lower respiratory tract
infections. We describe two novel approaches to the detection of viral RNA by use of reverse transcriptase PCR
(RT-PCR). The PCR products were identified after capture onto a solid-phase medium by hybridization with
a sequence-specific, biotinylated oligonucleotide probe. The assay was applied to the screening of 329 naso-
pharyngeal aspirates sampled from patients suffering from respiratory tract disease. These samples were
negative for other common microbial causes of respiratory tract disease. We were able to detect hMPV
sequences in 32 (9.7%) samples collected from Australian patients during 2001. To further reduce result
turnaround times we designed a fluorogenic TaqMan oligoprobe and combined it with the existing primers for
use on the LightCycler platform. The real-time RT-PCR proved to be highly reproducible and detected hMPV
in an additional 6 out of 62 samples (9.6%) tested during the comparison of the two diagnostic approaches. We
found the real-time RT-PCR to be the test of choice for future investigation of samples for hMPV due to its
speed, reproducibility, specificity, and sensitivity.
The recent description of a new member of the family
Paramyxoviridae, subfamily Pneumovirus, has provided an op-
portunity to define the extent of disease caused by this previ-
ously unknown human pathogen (12). Human metapneumovi-
rus (hMPV) has been detected in, and isolated from,
nasopharyngeal aspirates (NPA) taken from patients with re-
spiratory disease (9, 12).
Disease caused by hMPV appears similar to that caused by
human respiratory syncytial virus (hRSV), which is the most
significant cause of viral lower respiratory tract disease in in-
fants and children worldwide (2, 4, 5, 8, 10, 13). Patients show
symptoms ranging from a wheeze to bronchiolitis and may
require assisted ventilation.
The long-term presence of hMPV in the community has
been confirmed by detection of anti-hMPV antibodies during
retrospective seroepidemiological studies of stored Dutch sera
(12). The virus appears to infect the majority of The Nether-
lands’ population by the age of 5 years. Within our hospital
population, the causative viral agent of respiratory tract dis-
ease remains unidentified in 38 to 40% of patients examined.
Because the virus is difficult to detect by cell culture, due to
its selective, slow growth and mild cytopathicity and the ab-
sence of specific diagnostic reagents, the need for a reliable
and rapid diagnostic method is obvious. During the course of
routine culture to isolate respiratory viruses from these pa-
tients, cytopathicity is noticed. However, enzyme immunoas-
say, immunofluorescent assay, and reverse transcriptase PCR
(RT-PCR) for common viral and bacterial agents of respira-
tory disease fail to identify the cause. The hMPV negative-
sense RNA genome is only 20% homologous to the nucleo-
capsid (N) gene of hRSV and 52% homologous to avian
pneumovirus (14), so it is sufficiently distinct that its sequences
do not cross-react with existing nucleic acid amplification as-
says. Ideally, in addition to being specific, a new diagnostic
method should be rapid, sensitive, and able to be incorporated
into existing testing paradigms for the screening of respiratory
tract disease.
We describe the development of novel conventional RT-
PCR and real-time RT-PCR which utilizes the LightCycler
platform to detect hMPV RNA in patient samples. Using these
assays, we examined samples from patients with respiratory
tract disease of unknown etiology.
MATERIALS AND METHODS
Samples and RNA purification. Samples (n  329) were collected from March
to October 2001 from patients who tested negative for the common agents of
respiratory disease. In addition, samples (n  37) were included from patients
with previously diagnosed microbial causes of respiratory disease for use in the
specificity studies. These pathogens included Mycoplasma pneumoniae, adenovi-
rus, influenza virus, parainfluenza virus I-III, and hRSV. These microbial diag-
noses were made by validated cell culture or nucleic acid amplification assays.
Nucleic acids were also extracted from a range of microbes for use in cross-
reaction studies. These included Bacillus cereus, Bartonella henselae, Burkholderia
cepacia, Campylobacter coli, Candida albicans, coronavirus 229E, Cryptococcus
neoformans, Gardnerella vaginalis, Haemophilus influenzae, human rhinovirus,
Klebsiella pneumoniae, M. pneumoniae, Neisseria lactamica, Neisseria meningitidis,
Pseudomonas aeruginosa, Saccharomyces cerevisiae, Staphylococcus aureus, Staph-
ylococcus epidermidis, Staphylococcus hominis, Streptococcus pneumoniae, Strep-
tococcus pyogenes, and Vibrio parahaemolyticus.
Nucleic acids were purified from NPA placed in viral transport medium
(VTM). A spin column kit was used (High Pure viral nucleic acid kit; Roche
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Diagnostics, GmbH) according to the manufacturer’s instructions. Purified nu-
cleic acids and VTM were stored at 70°C.
Conventional PCR and nucleotide sequencing. RT-PCR was performed using
the SUPERSCRIPT One-Step system (Invitrogen, Melbourne, Australia). Each
25-l reaction contained 3 l of RNA, 3 mM MgSO4, 0.2 M (each) primers
(Table 1), and 5 M digoxigenin–11-dUTP (Roche Molecular Biochemicals,
GmbH). The reaction mixes were exposed to a 30-min, 50°C RT incubation and
then 45 cycles of 94°C for 20 s, 55°C for 20 s, and 68°C for 20 s, with a final 68°C
extension for 7 min. The amplification phase took approximately 2 h to complete
and resulted in a 213-nucleotide (nt) PCR product (amplicon).
The amplicon was purified from solution using a spin column kit (QIAquick;
Qiagen, Valencia, Calif.) according to the manufacturer’s instructions and was
then eluted into a final volume of 30 l. Nucleotide sequencing reactions were
prepared with the ABI PRISM BigDye cycle sequencing kit (Perkin Elmer
Applied Biosystems Division, Norwalk, Conn.) according to the manufacturer’s
instructions. Sequences were determined by an Applied Biosystems 377 DNA
sequencer.
Amplicon detection by ELAHA. Modifications were made to our previously
described enzyme-linked amplicon hybridization assay (ELAHA [7, 15]). These
consisted of a reduction in the total volume of the mixture to be denatured and
captured as well as a doubling of the length of the incubation of oligoprobe-
target duplex in the streptavidin-coated microwells. The new method combined
5 l of amplicon with 10 l of biotinylated oligoprobe (MPV P01; 0.2 M)
(Table 1) and 30 l of SSC (0.3 M NaCl, 0.15 M sodium citrate, pH 7.0). This
mixture was incubated at 95°C for 5 min and then rapidly cooled to 4°C using a
thermocycler. The oligoprobe-DNA complexes were captured onto the surfaces
of streptavidin-coated microwells during a 40-min incubation at 37°C. The mi-
crowells were washed three times with SSC. Each well was then incubated for 20
min at 37°C with 50 l of a peroxidase-labeled anti-digoxigenin–11-dUTP anti-
body (750 mU/ml; Roche Molecular Biochemicals, GmbH). Following another
three washes, 50 l of tetramethylbenzidine substrate (Astral Scientific, Gymea,
New South Wales, Australia) was incubated in each well at room temperature for
10 min. The reaction was stopped by the addition of 50 l of 1 M HCl per well.
The optical density of each microwell was determined by spectrophotometer at
a wavelength of 450 nm with a 690 nm reference filter (Murex Diagnostics,
Dartford, United Kingdom). Samples that returned values of at least 0.2 optical
density (OD) units were considered to contain hMPV RNA. This cutoff was
determined after studying the OD values produced by amplification and detec-
tion of the 37 samples used for the specificity study. The final cutoff was calcu-
lated as the mean of these values plus 4 standard deviations and the result was
rounded up to the first significant figure. The ELAHA took approximately 2 h to
perform, depending on the number of samples.
Real-time RT-PCR. Real-time RT-PCR was applied to the detection of viral
RNA using a single-tube RT-PCR kit according to the manufacturer’s instruc-
tions (RNA amplification kit for HybProbes; Roche Diagnostics, GmbH). The
amplification and detection were performed in the LightCycler, a combined
thermocycler and fluorimeter (Roche Diagnostics, GmbH). Each glass capillary
contained a 10-l reaction mix which included 3 l of purified sample RNA, 1.0
M sense primer (MPV01.2), 0.2 M antisense primer (MPV02.2), 7 mM
MgCl2, and 0.2 M fluorogenic endonuclease probe (TaqMan; TIB-MOLBIOL,
Berlin, Germany) labeled at the 5 end with FAM (6-carboxy-fluorescein) and at
the 3 end with TAMRA (6-carboxy-tetramethyl-rhodamine) (Table 1). The
reaction mixes were exposed to a 15-min, 50°C RT step, a 30-s denaturation at
95°C, and then 55 PCR cycles consisting of 94°C for 4 s, 55°C for 9 s, and 72°C
for 12 s, using a channel setting of F1/F2.
A dual-round, single-tube, real-time RT-PCR was performed in two steps. The
reaction mixes were created as described earlier, but they included a 0.2 M
symmetric primer mix and 10 l of mineral oil (Nujol; Perkin Elmer). The
capillaries were then capped, loaded into centrifuge adapters, and spun at 800 
g in a bench-top microcentrifuge. Next, the capillaries were returned to the
preparation area and uncapped, and 0.5 l of the previously described asym-
metric primer mix was added. The capillaries were then capped, loaded into the
LightCycler’s carousel, and spun in the carousel centrifuge (Roche Diagnostics,
GmbH). The first round of amplification incorporated reverse transcription,
denaturation of the RT, and 15 cycles of PCR. The samples were cooled to 40°C
and the carousel was removed, centrifuged, and replaced. The second round
consisted of an additional 40 cycles of PCR.
To investigate the efficiency of the amplification reaction and the nature of the
amplicon, fluorescence melting curve analysis was performed. At the completion
of the amplification phase, the amplicon was denatured at 95°C for 0 s and then
heated to 50°C and held for 30 s. Finally, the amplicon was heated to 95°C at
0.3°C/s while the fluorescent emissions were continuously monitored by the
LightCycler and presented as the negative derivative of the fluorescence over
time. The dual-round real-time RT-PCR took approximately 80 min to complete
compared to 60 min for the single-round assay.
Immunofluorescent assay. Aliquots of VTM which had been inoculated with
NPA from the patients previously described were added to cultures of monkey
kidney or human lung epithelial cells (LLC MK2 or A549, respectively) in the
presence of 10% (vol/vol) fetal calf serum, 50 M penicillin G, 50 g of strep-
tomycin sulfate per ml, and 0.02% trypsin (Invitrogen). Cultures were main-
tained for a week before screening of the supernatant and cells by real-time
RT-PCR commenced. Mock-infected or hRSV-infected cultures were grown and
screened in parallel. When cytopathic effects became apparent, culture super-
natant and cells were used to infect fresh cell monolayers growing on chamber
slides (Nunc, Rochester, N.Y.). Dried monolayers were probed using a diluted
adult serum. Positive cells were detected after incubation with a fluorescein
isothiocyanate-conjugated secondary antibody.
Nucleotide sequence accession numbers. Sequences containing the amplicon
described in this paper were deposited into the GenBank database under the
accession numbers AF442513-6 and AF443830-4.
RESULTS
Primer and oligoprobe specificity. A range of related and
unrelated nucleic acid templates were subjected to PCR using
primers MPV01.2 and MPV02.2, which are common to both
assays. No signal was produced in the ELAHA or the real-time
RT-PCR from any of these reactions (data not shown). To
further examine the specificity of the ELAHA, a strongly pos-
itive hMPV amplicon was denatured in the presence of a series
of biotinylated oligoprobes. The oligoprobes ranged in size
from 23 to 28 nt and were designed for use in ELAHA to
detect hRSV, influenza viruses, rhinoviruses, M. pneumoniae,
parainfluenza viruses, adenoviruses, herpesviruses, human
coronavirus, Candida species, Aspergillus species, measles vi-
rus, enteroviruses, the malarial parasites, Treponema pallidum,
parvovirus B19, and Klebsiella species. No signal was produced
using any of these templates, confirming that the hMPV assays
are highly specific and that hybridization by ELAHA is a suit-
ably stringent technique (data not shown).
Relative sensitivity of the ELAHA. To investigate how sen-
sitive the modified ELAHA was in comparison to a traditional
amplicon detection method, we made serial twofold dilutions
of an hMPV amplicon and examined 5 l by agarose gel
electrophoresis and ELAHA. The results revealed a 512-fold
improvement in the sensitivity of the ELAHA compared to
electrophoresis (Fig. 1). To examine the effect of an asymmet-
ric PCR primer mix on the ELAHA, the antisense primer
concentration was increased fivefold in an effort to make more
of the strand to which the biotinylated oligoprobe will hybrid-
ize. This produced an increased signal, resulting in at least a
fourfold increase in the sensitivity of amplicon detection (Fig.
2).
TABLE 1. Nucleotide sequences of sense (01) and antisense (02)
oligonucleotide primers and biotinylated (MPV P01) or fluorogenic
endonuclease (MPV TM02) oligoprobesa
Primer Sequence
MPV01.2............AAC CGT GTA CTA AGT GAT GCA CTC
MPV02.2............CAT TGT TTG ACC GGC CCC ATA A
MPV P01...........Biotin-GAA GTT TGT TCA TTG AGT ATG G
MPV TM02.......FAM-CTT TGC CAT ACT CAA TGA ACA AAC-
TAMRA
a Designs were based on the hMPV N gene sequence available from GenBank
under accession number AF371337.
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Real-time RT-PCR. To further reduce the turn-around time
of the RT-PCR–ELAHA, we converted the conventional PCR
to a real-time RT-PCR, which incorporated the same primers
and included a fluorogenic oligoprobe. During this assay the
LightCycler instrument continuously monitored amplicon ac-
cumulation by detecting the proportional increase in fluores-
cence emitted as the result of a loss of quenching of the FAM
reporter fluorophore as the oligoprobe was hydrolyzed. The
real-time assay was at least 180 min faster than the RT-PCR–
ELAHA, taking approximately 60 min for 32 samples. In ad-
dition, there was no need to open the capillary to detect am-
plicon, thus significantly restricting the potential for carryover
contamination.
Assay reproducibility, based on analysis of the fractional
cycle number at which the fluorescence generated by the ac-
cumulating amplicon exceeds the baseline (threshold cycle
[CT]), was determined after examining replicate samples, using
different vials of RT-PCR master mix. Six replicates were as-
sayed in each run, and this was performed by the same tech-
nician on different days. The assay gave highly reproducible
results, with intra-assay coefficients of variation (CV) of 0.4 to
2% and an interassay CV of 3%.
Although the TaqMan and ELAHA oligoprobes hybridize
with an almost identical sequence of the hMPV N gene, the
target sequences are on opposite strands. This design was nec-
essary in order to avoid a guanine on the template strand,
which would occur adjacent to the FAM reporter molecule,
resulting in nonspecific quenching.
To study the efficiency of oligoprobe hydrolysis and, by ex-
trapolation, the efficiency of the real-time PCR, we applied
fluorescent melting curve analysis to the amplicon produced in
the presence of an asymmetric primer mix. This resulted in a
peak that was specific for the hMPV oligoprobe’s nucleotide
sequence and approximated its expected melting temperature
(Tm) (Fig. 3A). When the kinetic curves were examined, it was
apparent that the only reactions producing a melt curve were
those containing a fivefold excess of the sense primer which
produces the fluorogenic oligoprobe’s target strand (Fig. 3B).
The CT value decreased when using this primer mix; however,
the kinetic curves reached a plateau earlier, resulting in short
log-linear phases (LP). This is of concern if the assay is to be
used quantitatively or if samples contain low levels of RNA
template (Fig. 4). The product of reverse transcription of
hMPV negative-sense RNA is positive-sense DNA, which is
also the fluorogenic oligoprobe’s target. We hypothesized that
an asymmetric primer mix designed to produce an excess of the
sense strand is not conducive, at least in the early cycles of
PCR, to efficient exponential amplification of a sense-strand
DNA due to the initial absence of negative-sense template
DNA. We examined whether this was likely to reduce the PCR
efficiency by developing a dual-round, real-time RT-PCR in
which the first round of 15 cycles used a symmetric primer mix
of MPV01.2 and MPV02.2 at 2 M in order to allow the
relatively unbiased reverse transcription and subsequent cre-
ation of antisense strands by PCR. The first round was sepa-
rated from an asymmetric primer mix by a barrier of mineral
oil. Prior to the second round of amplification, the capillaries
were centrifuged, introducing the asymmetric primer combi-
nation, which contained a fivefold excess of the sense primer,
to the PCR mix. While this format added approximately 15 min
to the real-time assay, it retained the homogenous nature of
real-time PCR. The dual-round assay produced reduced CT
values for the detection of weakly positive RNA templates and
improved PCR performance as gauged by the more pro-
nounced linear phase of amplification seen in the resultant
PCR curves of strongly positive templates (Fig. 4).
Rather than redesign the oligoprobe to hybridize to a loca-
tion on the antisense strand, we investigated whether reversing
the order of the asymmetric primer mix would improve the
signal. Using 2 and 10 M MPV01.2 and MPV02.2 primers,
respectively, we were able to show improved amplification of
FIG. 1. Titration of 5-l aliquots of hMPV amplicon and detection
by ELAHA. The inset panel displays the first three corresponding
bands on an agarose gel. There is a faint band visible up to a dilution
of 1:2, whereas the ELAHA is positive to a dilution of 1:1,024. The
horizontal line represents the ELAHA cutoff value of 0.2 OD units.
FIG. 2. Comparison of assay sensitivity using symmetric (filled
bars) (0.2 M sense and antisense primers) and asymmetric (open
bars) (0.2 M sense and 1.0 M antisense primers) RT-PCR–
ELAHA. The cutoff for a positive ELAHA result is shown as a broken,
horizontal line.
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the weakly positive RNA, producing a better quality of kinetic
curve in the absence of a melt peak (Fig. 5).
Specimen testing and comparative assay sensitivity. Ini-
tially, the RT-PCR–ELAHA had been used to screen 329 NPA
samples, detecting hMPV sequences in 32 (9.7%) of these.
To compare the ability of the real-time assay to detect tem-
plate, fivefold dilutions of supernatant from an hMPV-positive
culture were tested by both assays. The RT-PCR–ELAHA and
the real-time RT-PCR were capable of detecting hMPV se-
quences to a dilution of 1:125, indicating equivalent analytical
sensitivity (data not shown).
To evaluate the clinical sensitivity of these assays under
routine conditions, a subset of 62 NPA samples was chosen for
investigation using both assays. This subset contained 6 hMPV
RNA-positive samples and 56 samples that did not contain
hMPV RNA as determined by RT-PCR–ELAHA. The real-
time assay detected hMPV sequences in an additional 6 of
these specimens, bringing the total number of hMPV-positive
samples to 12. This was equivalent to an improvement in the
rate of detection of 9.6% within this population.
Sequencing of the amplicon. To further ensure that the
amplicon produced from these assays was due to the amplifi-
cation of a portion of the hMPV N gene, nucleotide sequenc-
ing was performed.
Confirmation of active hMPV infection. In order to confirm
that our assays were detecting an active viral infection, cell
cultures were incubated with VTM when sufficient volume was
available (at least 200 l) and provided that normal flora had
not overgrown the sample during transport or specimen han-
dling.
Virus was passaged several times and the status of virus
replication monitored by real-time RT-PCR. In mock-infected
or hRSV-infected control cell cultures, no PCR product was
produced during any stage of the culture process. To further
confirm that virus was actively replicating, immunofluores-
cence studies were performed on cells taken from RT-PCR
positive cultures and probed using an adult serum. Positive,
bright green cells were observed either singly or in adjacent
clusters.
DISCUSSION
We have described the detection of hMPV from Australian
children and infants by two newly developed RT-PCR assays.
The need for rapid diagnosis of respiratory tract disease is
acutely important during seasonal outbreaks of the causative
agents (6).
Using these assays we were able to detect virus in 10% of
local NPA samples collected during the period from March to
October 2001, and subsequent isolation of hMPV was possible
from RT-PCR positive VTMs stored at 70°C. These samples
originated from patients presenting to the hospital with respi-
ratory tract disease of an otherwise unknown microbial origin.
Our rate of detection is identical to that reported by van den
FIG. 3. The effect of an asymmetric primer mix on the reaction
efficiency of a strong hMPV-positive patient sample. Fluorescent melt-
ing-curve analysis (A) only produced peaks from the amplicon that was
created in the presence of an excess of sense primer (0.5 M
MPV01.2–0.2 M MPV02.2 or 1.0 M MPV01.2–0.2 M MPV02.2,
indicated by a solid or broken line, respectively, with crosses), whereas
amplification using an excess of antisense primer (0.2 M MPV01.2–
0.5 M MPV02.2 or 0.2 M MPV01.2–1.0 M MPV02.2, indicated by
a solid or broken line, respectively, without crosses) (B) produced a
higher amplicon yield and extended the LP of amplification.
FIG. 4. A weakly hMPV-positive patient sample was amplified by
single-round (broken line) or dual-round (solid line) real-time RT-
PCR. The second step of the reaction incorporated an asymmetric
primer mix containing a fivefold excess of sense primer.
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Hoogen et al. in their prospective studies of children who
presented to a medical center with respiratory tract disease
and were found to be RT-PCR positive for hMPV (14).
Neither of our assays cross-reacted with nucleic acids puri-
fied from the other common microbial agents of respiratory
tract disease. This was examined both at the level of amplifi-
cation by detection of the amplicon using agarose gel electro-
phoresis and at the level of detection by testing the specificity
of the oligoprobes.
In our conventional RT-PCR assay, we replaced dTTP in the
nucleotide mix with twice as much dUTP in order to allow the
use of uracil-N-glycosylase pretreatment to control a possible
contamination event. However, to date the careful separation
of mix preparation, template addition, and postamplification
areas as well as the use of dedicated lab coats, pipettes, and
filtered pipette tips has protected this assay from contamina-
tion.
While optimizing the ELAHA, we applied an asymmetric
primer mix designed to produce more of the strand to which
the oligoprobe hybridized. We found that this improved the
sensitivity of the assay at least twofold. This was in addition to
a 512-fold improvement in amplicon detection compared to
agarose gel electrophoresis.
Real-time PCR assays are ideal for use in studying the epi-
demiology of a newly described virus because the systems are
homogeneous, combining nucleic acid amplification and detec-
tion in a single closed reaction vessel. This means that the
amplicon can be discarded without ever exposing the environ-
ment to contamination, the preferred approach for a high-
throughput molecular diagnostic laboratory. This feature is
additionally important when studying a new virus, as amplicon
contamination could prove disastrous to the process of virus
characterization.
In order to accurately compare the conventional and real-
time RT-PCR assays, we chose to target the same sequence
with both oligoprobes. However, this was not possible due to a
guanine nucleotide that would have been incorporated into the
5 end of the fluorogenic oligoprobe, causing quenching of the
reporter fluorophore (3). Therefore, we designed the fluoro-
genic oligoprobe’s sequence to be the reverse complement of
that used in the ELAHA, so that it would hybridize with the
sense strand of the amplified DNA. In an attempt to increase
the fluorescent signal from weakly positive samples, we used an
asymmetric primer mix to create more of the DNA strand to
which the fluorogenic oligoprobe hybridizes. However, a prob-
lem arose that manifested as an early plateau in amplicon
detection. We developed a dual-round RT-PCR to further
examine the effects of asymmetric PCR using this primer mix.
The dual-round approach has been used for nested PCR using
the LightCycler (1, 11). We modified this approach by sepa-
rating two concentrations of primers rather than two different
primer pairs. The results confirmed that the asymmetric primer
mix we were using was unsuitable for the detection of low
levels of hMPV RNA. Following reverse transcription, there is
an abundance of sense strands, but no antisense strands, for
the sense primer to hybridize with. In the presence of an excess
of the antisense primer, however, the PCR can effectively
reach exponential levels of amplification. Therefore, when an
oligoprobe is used to detect a negative-sense RNA genome by
single-tube RT-PCR, the inclusion of asymmetric primers
needs to be carefully considered.
To investigate the efficiency of hydrolysis of the fluorogenic
oligoprobe under asymmetric PCR conditions and, by extrap-
olation, the efficiency of the real-time PCR assay, we applied
fluorescent melting-curve analysis to the amplicon. Melting
peaks were obtained from reactions containing an excess of the
sense primer but not from reactions with extra antisense
primer. We believe these melting peaks are due to conforma-
tional changes occurring when intact hybridized oligoprobe is
melted from its template. This reduces the “leaky” fluores-
cence which results from an incompletely quenched FAM mol-
ecule when it is maximally separated from TAMRA on an
intact oligoprobe. As the oligoprobe returns to a relaxed state
after it has melted from its template, the fluorophores are
more likely to interact by molecular collision, increasing the
extent of quenching. The entire process results in a decreased
fluorescence, which is presented as a melting peak when the
negative derivative of the rate of change in fluorescence is
calculated by the LightCycler’s software. The fact that this
signal is only apparent from reaction mixes containing an ex-
cess of sense primer which achieve an early plateau of signal
suggests that there is an excess of intact fluorogenic oligoprobe
FIG. 5. Using the same weakly positive patient sample that was
used for Fig. 4, hMPV RNA was amplified by single-round RT-PCR
using asymmetric primers with a fivefold excess of the sense primer,
MPV01.2 (broken line), or of the antisense primer, MPV02.2 (solid
line). The kinetic curves indicate that the latter primer mix is superior
(A) and this is confirmed by the melt analysis which shows incomplete
oligoprobe hydrolysis when using more of the sense primer (B).
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and that this may be a useful marker of the efficiency of a
real-time PCR using this detection chemistry.
We discovered that although the two assays possessed equal
analytical sensitivity, the real-time RT-PCR was more sensitive
than the RT-PCR–ELAHA in clinical studies. This could be
caused by differential effects due to the presence of inhibitors
of the RT or PCR steps in the conventional assay or differences
between the capabilities of the single-tube RT-PCR kits used
for the two assays.
In conclusion, we have compared two rapid molecular diag-
nostic approaches for the amplification and detection of
hMPV RNA. These assays can also be used to examine and
define an improved model for culturing hMPV, which cur-
rently relies upon cell lines that show little to no effect of
hMPV replication. The results show that although the analyt-
ical sensitivities of the assays were identical, upon testing the
assays using clinical samples, the real-time RT-PCR had an
improved sensitivity, was faster and more cost-effective, and
greatly reduced the likelihood of environmental contamination
by amplicon. Thus, it is the preferred choice for detecting the
presence of a newly described viral pathogen in the routine
laboratory, proving considerably more reliable than cell culture
for diagnosing hMPV infection.
ACKNOWLEDGMENTS
This work was supported by the Royal Children’s Hospital Founda-
tion grant number 922-034, which was sponsored by the Woolworth’s
“Care for Kids” campaign, and number R912-006, which supported
this work.
We thank Andreas Nitsche for useful discussions and Katherine
Arden for critical review of the manuscript.
REFERENCES
1. Berg, J., V. Nagl, G. Mu¨hlbauer, and H. Stekel. 2001. Single-tube two-round
polymerase chain reaction using the LightCycler instrument. J. Clin. Virol.
20:71–75.
2. Collins, P. L., K. McIntosh, and R. M. Chanock. 1996. Respiratory syncytial
virus, p. 1313–1351. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.),
Fields virology. Lippincott-Raven, Philadelphia, Pa.
3. Crockett, A. O., and C. T. Wittwer. 2001. Fluorescein-labelled oligonucleo-
tides for real-time PCR: using the inherent quenching of deoxyguanosine
nucleotides. Anal. Biochem. 290:89–97.
4. Domachowske, J. B., and H. F. Rosenberg. 1999. Respiratory syncytial virus
infection: immune response, immunopathogenesis, and treatment. Clin. Mi-
crobiol. Rev. 12:298–309.
5. Holberg, C. J., A. L. Wright, F. D. Martinez, C. G. Ray, L. M. Taussig, and
M. D. Lebowitz. 1991. Risk factors for respiratory syncytial virus-induced
lower respiratory illnesses in the first year of life. Am. J. Epidemiol. 133:
1135–1151.
6. Lipson, S. M. 2002. Rapid laboratory diagnostics during the winter respira-
tory virus season. J. Clin. Microbiol. 40:733–734.
7. Mackay, I. M., P. Metharom, T. P. Sloots, and M. Q. Wei. 2001. Quantitative
PCR-ELAHA for the determination of retroviral vector transduction effi-
ciency. Mol. Ther. 3:801–807.
8. McClelland, L., M. R. Hilleman, V. V. Hamparian, A. Ketler, C. M. Reilly,
and D. Cornfeld. 1961. Studies of acute respiratory illnesses caused by
respiratory syncytial virus. N. Engl. J. Med. 264:1169–1175.
9. Nissen, M. D., D. J. Siebert, I. M. Mackay, T. P. Sloots, and S. J. Withers.
2002. Evidence of human metapneumovirus in Australian children. Med. J.
Aust. 176:188.
10. Ralph, D., M. McClelland, and J. Welsh. 1993. RNA fingerprinting using
arbitrarily primed PCR identifies differentially regulated RNAs in mink lung
(My1Lu) cells growth arrested by transforming growth factor 1. Proc. Natl.
Acad. Sci. USA 90:10710–10714.
11. Ratge, D., B. Scheiblhuber, O. Landt, J. Berg, and C. Knabbe. 2002. Two-
round rapid-cycle RT-PCR in single closed capillaries increases the sensi-
tivity of HCV RNA detection and avoids amplicon carry-over. J. Clin. Virol.
24:161–172.
12. Schutten, M., B. van den Hoogen, M. E. van der Ende, R. A. Gruters,
A. D. M. E. Osterhaus, and H. G. M. Niesters. 2000. Development of a
real-time quantitative RT-PCR for the detection of HIV-2 RNA in plasma.
J. Virol. Methods 88:81–87.
13. Selwyn, B. J. 1990. The epidemiology of acute respiratory tract infection in
young children: comparison of findings from several developing countries.
Rev. Infect. Dis. 12:S870–S888.
14. van den Hoogen, B. G., J. C. de Jong, J. Groen, T. Kuiken, R. de Groot,
R. A. M. Fouchier, and A. D. M. E. Osterhaus. 2001. A newly discovered
human pneumovirus isolated from young children with respiratory tract
disease. Nat. Med. 7:719–724.
15. Whiley, D. M., I. M. Mackay, and T. P. Sloots. 2001. Detection and differ-
entiation of human polyomaviruses JC and BK by LightCycler PCR. J. Clin.
Microbiol. 39:4357–4361.
VOL. 41, 2003 MOLECULAR ASSAYS FOR DETECTION OF hMPV 105
 o
n
 O
ctober 22, 2015 by University of Queensland Library
http://jcm.asm.org/
D
ow
nloaded from
 
